BOMBAY BURMAH TRADING CORPORATION
Back to Balance Sheet
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹321 Cr | ₹460 Cr | ₹396 Cr | ₹389 Cr | ₹412 Cr |
What is the latest Contingent Liabilities ratio of BOMBAY BURMAH TRADING CORPORATION ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹321 Cr |
Mar2024 | ₹460 Cr |
Mar2023 | ₹396 Cr |
Mar2022 | ₹389 Cr |
Mar2021 | ₹412 Cr |
How is Contingent Liabilities of BOMBAY BURMAH TRADING CORPORATION Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹321 Cr | -30.28 | |
Mar2024 | ₹460 Cr | 16.34 | |
Mar2023 | ₹396 Cr | 1.73 | |
Mar2022 | ₹389 Cr | -5.65 | |
Mar2021 | ₹412 Cr | - |
Compare Contingent Liabilities of peers of BOMBAY BURMAH TRADING CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BOMBAY BURMAH TRADING CORPORATION | ₹13,273.2 Cr | -0.8% | -3.8% | -16.9% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,584.5 Cr | -2% | -8.8% | 3.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,119.4 Cr | -1.5% | -6.5% | -23.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,421.2 Cr | 1.2% | -3.8% | -31.6% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹569.5 Cr | 0.7% | 13.1% | NA | Stock Analytics | |
INDO US BIOTECH | ₹339.7 Cr | 5.8% | 11.2% | -20.5% | Stock Analytics |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BOMBAY BURMAH TRADING CORPORATION | -0.8% |
-3.8% |
-16.9% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses